» Articles » PMID: 32066485

YAP1 Plays a Key Role of the Conversion of Normal Fibroblasts into Cancer-associated Fibroblasts That Contribute to Prostate Cancer Progression

Overview
Publisher Biomed Central
Specialty Oncology
Date 2020 Feb 19
PMID 32066485
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer-associated fibroblasts (CAFs) are an important part of the tumour microenvironment, and their functions are of great concern. This series of experiments aimed to explore how Yes-associated protein 1 (YAP1) regulates the function of stromal cells and how the normal fibroblasts (NFs) convert into CAFs in prostate cancer (PCa).

Methods: The effects of conditioned media from different fibroblasts on the proliferation and invasion of epithelial cells TrampC1 were examined. We then analysed the interaction between the YAP1/TEAD1 protein complex and SRC, as well as the regulatory function of the downstream cytoskeletal proteins and actins. A transplanted tumour model was used to explore the function of YAP1 in regulating tumour growth through stromal cells. The relationship between the expression of YAP1 in tumour stromal cells and the clinical characteristics of PCa patients was analysed.

Results: The expression level of YAP1 was significantly upregulated in PCa stromal cells. After the expression level of YAP1 was increased, NF was transformed into CAF, enhancing the proliferation and invasion ability of epithelial cells. The YAP1/TEAD1 protein complex had the capability to influence downstream cytoskeletal proteins by regulating SRC transcription; therefore, it converts NF to CAF, and CAF can significantly promote tumour growth and metastasis. The high expression of YAP1 in the tumour stromal cells suggested a poor tumour stage and prognosis in PCa patients.

Conclusion: YAP1 can convert NFs into CAFs in the tumour microenvironment of PCa, thus promoting the development and metastasis of PCa. Silencing YAP1 in tumour stromal cells can effectively inhibit tumour growth.

Citing Articles

Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts.

Gelsomino L, Caruso A, Tasan E, Leonetti A, Malivindi R, Naimo G Cell Commun Signal. 2024; 22(1):545.

PMID: 39543704 PMC: 11566413. DOI: 10.1186/s12964-024-01918-x.


Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota.

Chen L, Xu Y, Wang Y, Ren Y, Dong X, Wu P Mol Cancer. 2024; 23(1):229.

PMID: 39395984 PMC: 11470719. DOI: 10.1186/s12943-024-02137-1.


Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer.

Yu J, Zhang M, Li T, Gao W, Yang Z, Wang K Oncogene. 2024; 43(38):2835-2849.

PMID: 39155296 DOI: 10.1038/s41388-024-03132-y.


YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer.

Song H, Lu T, Han D, Zhang J, Gan L, Xu C Cancer Res. 2024; 84(22):3728-3742.

PMID: 39137404 PMC: 11565174. DOI: 10.1158/0008-5472.CAN-24-0932.


Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression.

Chen H, Fang S, Zhu X, Liu H Front Cell Dev Biol. 2024; 12:1412337.

PMID: 39092186 PMC: 11291335. DOI: 10.3389/fcell.2024.1412337.


References
1.
Luo Y, Lan L, Jiang Y, Zhao J, Li M, Wei N . Epithelial-mesenchymal transition and migration of prostate cancer stem cells is driven by cancer-associated fibroblasts in an HIF-1α/β-catenin-dependent pathway. Mol Cells. 2013; 36(2):138-44. PMC: 3887956. DOI: 10.1007/s10059-013-0096-8. View

2.
Albrengues J, Bertero T, Grasset E, Bonan S, Maiel M, Bourget I . Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat Commun. 2015; 6:10204. PMC: 4682161. DOI: 10.1038/ncomms10204. View

3.
Chen X, Song E . Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2018; 18(2):99-115. DOI: 10.1038/s41573-018-0004-1. View

4.
Drummond M, Li M, Tarapore E, Nguyen T, Barouni B, Cruz S . Actin polymerization controls cilia-mediated signaling. J Cell Biol. 2018; 217(9):3255-3266. PMC: 6122990. DOI: 10.1083/jcb.201703196. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View